Researchers employed integrated bioinformatic analysis to identify calpain-2 as a novel key regulator for Lenvatinib resistance in HCC, and its expression greatly increased in both Lenvatinib-resistant HCC cell lines and clinical samples.
[Molecular Biomedicine]
